Hepatitis B virus: inactive carriers.
Sharma SK, Saini N, Chwla Y.
Virol J. 2005 Sep 28;2:82. doi: 10.1186/1743-422X-2-82.
Chinese herbal medicine for carriers of the hepatitis B virus: an updated systematic review and meta-analysis.
Yang Y, Jiang HY, Shi Y, He JL, Su S, Chen Z.
Pharmazie. 2014 Oct;69(10):723-30.
Introduction to 'Hepatitis B virus heterogeneity--a means to personalized care'.
Bonino F; 'Hepatitis B virus heterogeneity--a means to personalized care' steering committee.
Antivir Ther. 2010;15 Suppl 3:1-2. doi: 10.3851/IMP1618.
Hepatitis B vaccine.
[No authors listed]
Lancet. 1980 Dec 6;2(8206):1229-30.
Does isoniazid cause more serious hepatotoxicity in hepatitis B virus carriers?
Nguyen MH, Garcia G.
Am J Gastroenterol. 2002 May;97(5):1092-3. doi: 10.1111/j.1572-0241.2002.05700.x.
Novel hepatitis B virus subgenotype A8 and quasi-subgenotype D12 in African-Belgian chronic carriers.
Thijssen M, Trovão NS, Mina T, Maes P, Pourkarim MR.
Int J Infect Dis. 2020 Apr;93:98-101. doi: 10.1016/j.ijid.2020.01.048. Epub 2020 Jan 28.
Are hepatitis B carriers more vulnerable to exercise-related liver injury? Recent evidence from a 7-day ultramarathon.
Huang YS.
J Chin Med Assoc. 2016 Apr;79(4):169-70. doi: 10.1016/j.jcma.2015.12.003. Epub 2016 Feb 22.
Hepatitis B virus and primary hepatocellular carcinoma: treatment of HBV carriers with Phyllanthus amarus.
Blumberg BS, Millman I, Venkateswaran PS, Thyagarajan SP.
Vaccine. 1990 Mar;8 Suppl:S86-92. doi: 10.1016/0264-410x(90)90225-b.
Chronic carriers of hepatitis B virus who clear hepatitis B surface antigen: are they really "off the hook"?
McMahon BJ.
Hepatology. 1998 Jul;28(1):265-7. doi: 10.1002/hep.510280135.
Impairment of the metabolism of dipyrone in asymptomatic carriers of the hepatitis B virus.
Levy M, Leibowich I, Zylber-Katz E, Ilan Y, Granit L, Sviri S, Caraco Y.
Clin Pharmacol Ther. 1997 Jul;62(1):6-14. doi: 10.1016/S0009-9236(97)90145-4.
